S-(2,3-Bis(palmitoyloxy)propyl)-N-palmitoyl-L-cysteinyl-L-seryl-L-lysyl-L-lysyl-L-lysyl-L-lysine trihydrochloride

Catalog No. :
ACSUPK532
CAS No. :
112208-04-5
Molecular Formula :
C81H159Cl3N10O13S
Molecular Weight :
1619.65

IUPAC Name:S-(2,3-bis(palmitoyloxy)propyl)-N-palmitoyl-L-cysteinyl-L-seryl-L-lysyl-L-lysyl-L-lysyl-L-lysine trihydrochloride

S-(2,3-Bis(palmitoyloxy)propyl)-N-palmitoyl-L-cysteinyl-L-seryl-L-lysyl-L-lysyl-L-lysyl-L-lysine trihydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameS-(2,3-Bis(palmitoyloxy)propyl)-N-palmitoyl-L-cysteinyl-L-seryl-L-lysyl-L-lysyl-L-lysyl-L-lysine trihydrochloride
IUPAC NameS-(2,3-bis(palmitoyloxy)propyl)-N-palmitoyl-L-cysteinyl-L-seryl-L-lysyl-L-lysyl-L-lysyl-L-lysine trihydrochloride
Molecular FormulaC81H159Cl3N10O13S
Molecular Weight1619.65
SMILESCCCCCCCCCCCCCCCC(=O)N[C@@H](CSCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O.Cl.Cl.Cl
InChI KeyINNTZVXVIZIYBF-PXSLIBMESA-N
SynonymP3CSK4 3HCL;PAM3CSK4 3HCL;PAM3 CYS-SK4, 3HCL;PAM3 CYS-SER-(LYS)4, HYDROCHLORIDE;PAM3CYS-SER-(LYS)4 TRIHYDROCHLORIDE;(S)-[2,3-BIS(PALMITOYLOXY)-(2-RS)-PROPYL]-N-PALMITOYL-(R)-CYS-(S)-SER-(S)-LYS4-OH 3 HCL;Pam3CSK4 (trihydrochloride)
CAS No.112208-04-5

Synthetic Route by SureRoute

1. ACSUPK532 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSUPK532 route product structure diagram
    ACSUPK532112208-04-5
Inquiry

2. ACSUPK532 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSUPK532 route product structure diagram
    ACSUPK532112208-04-5
Inquiry

Comments (0)